Through the Foundation research is turned into reality enabling patients in the Epatocentro to access cutting edge therapeutic opportunities and, in the context of a clinical study, innovative treatments 1 - 2 years before they are released onto the market.
The Foundation actively participates in clinical research protocols especially in the field of new drugs for the treatment of chronic hepatitis C, hepatitis B and other hepatic diseases;
The contribution made by the centre in this field is evidenced by the results achieved including:
The centre participates in projects supported by national bodies and research laboratories such as:
Swiss Cohort Study for Hepatitis C
Swiss Cohort Study of transplant patients
Swiss HIV Cohort Study (SHCS)